1991
DOI: 10.1136/ard.50.11.800
|View full text |Cite
|
Sign up to set email alerts
|

A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.

Abstract: Objective-To compare low (0.5 ng/kg/min) and standard dose (2 ng/kg/min) iloprost (a stable carbacyclin analogue of prostacyclin) in patients with Raynaud's phenomenon secondary to connective tissue disorders.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
17
0
10

Year Published

1991
1991
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(39 citation statements)
references
References 24 publications
2
17
0
10
Order By: Relevance
“…Tcell clones were made as described previously [14, [18], deletion mutants of the M . bovis BCG hsp65 [12] and peptides synthesized according to the sequence of the M .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Tcell clones were made as described previously [14, [18], deletion mutants of the M . bovis BCG hsp65 [12] and peptides synthesized according to the sequence of the M .…”
Section: Methodsmentioning
confidence: 99%
“…All Tcell lines were tested in a proliferation assay with a 65-kDa protein of M . bovis [18] and M . leprue [17] DR1 and six via DR3.…”
Section: Hsp 65 Reactivity and Hla-dr Restriction Specificity Of Antimentioning
confidence: 99%
“…It has been shown to reduce the severity, frequency and duration of vasospastic events and promote healing of ischaemic ulcers. [4][5][6] There have been several, long-term, randomised trials on prostacyclin analogues versus placebo patients with Fontaine's stages III and IV; 6,7 these have shown a beneficial effect. The recommendation from the Trans-Atlantic Inter-Society Consensus (TASC) is that the use of prostanoids in end-stage critical limb ischaemia maybe of use in preventing further tissue loss or amputation.…”
Section: Discussionmentioning
confidence: 99%
“…hsp 60 for immunization was produced, isolated and purified from E. coli clone M1546 [9] essentially as described earlier [ 101 .The hyperimmune polyclonal rabbit IgG fraction (rb-a-60) was prepared by affinity purification on a protein A-Superose (Pharmacia, Freiburg, FRG) column and titrated for saturating concentration on BMMQ cells by FCM. As a negative control we used a normal rabbit IgG preparation which had been absorbed on an hsp 60 affinity column (CNBr-Sepharose coupled with purified rhsp 60 of M. bovis BCG following the instruction of Pharmacia) to remove contaminating naturally occurring anti-hsp 60 antibodies.…”
Section: Antisera and Mabmentioning
confidence: 99%